Symptomtext
temperature excursion; Initial information received on 14-Feb-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient with unknown demographics who had temperature excursion while receiving vaccines [ADACEL], [IPOL], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL], DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] and HIB (PRP/T) VACCINE [ACT-HIB] and while treated with TUBERCULIN TEST [TUBERSOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) Solution for injection dosage unknown (lot - C582AA) for Product used for unknown indication. On an unknown date, the patient received a dose of suspect HIB (PRP/T) VACCINE lot UJ603AAA via unknown route in unknown administration site for immunization. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C59700A via unknown route in unknown administration site immunization. On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ597AAA via unknown route in unknown administration site immunization. On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5816AA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect IPV (VERO) lot V1A011M via unknown route in unknown administration site immunization. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U7093AA via unknown route in unknown administration site immunization. On an unknown date the patient had temperature excursion (product temperature excursion issue) (unknown latency) following the first dose intake and (unknown latency) following the last dose intake of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (temperature excursion). At time of reporting, the outcome was Unknown for the event temperature excursion.